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Barberá3, Marı́a S. Caleprico1, Vicente Vicente3, Vanessa Roldán3, Rocı́o González-
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Abstract
Background
Atherosclerosis involves activation of the IRAK1/TRAF6/NF-κB inflammatory cascade,
which is negatively regulated by miR146a. Previous studies showed that the TT genotype of
rs2431697, located near the miR-146a gene, drives lower miR-146a transcription and pre-
dicts adverse cardiovascular events in anticoagulated atrial fibrillation patients. Moreover,
systemic miR-146a administration protects mice from atherosclerosis. Here we evaluated
the ability of miR-146a expression in the hematopoietic component to regulate atherosclero-
sis in low-density lipoprotein receptor-null mice (Ldlr-/-).
Methods and results
Lethally-irradiated Ldlr-/- mice transplanted with bone marrow from wild-type or miR-146a-
null mice were fed an atherogenic diet for 8 and 20 weeks. Irak1, Traf6 and MIR146A
expression were quantified in thoracic aorta by qRT-PCR and Western blot. Aortic plaque
size and composition were characterized by Oil-Red staining and immunohistochemistry
and leukocyte recruitment by intravital microscopy. Blood cell counts were similar in fat-fed
Ldlr-/-mice with or without hematopoietic miR-146a expression. However, plasma choles-
terol decreased in fat-fed Ldlr-/-mice transplanted with bone marrow deficient for miR-146a.
Finally, aortic atherosclerosis burden and recruitment of leukocytes into the vessel wall
were undistinguishable between the two groups, despite higher levels of Irak1 and Traf6
mRNA and protein in the aorta of fat-fed mice lacking hematopoietic miR-146a expression.
Conclusions
miR-146a deficiency exclusively in hematopoietic cells modulates cholesterol levels in
plasma and the expression of its targets in the artery wall of fat-fed Ldlr-/- mice, but does not
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Introduction
Atherosclerosis is a complex inflammatory process involving several factors and cell types that
interact in response to different forms of injury [1]. Together with endothelium and smooth
muscle cells, hematopoietic cells play a central role in atherogenesis [2]. Indeed, a key early
event in the inflammatory response during atherosclerosis is the adhesion of neutrophils to the
vascular endothelium and their recruitment into the injured artery wall. The secretion of neu-
trophil-derived myeloperoxidase seems to be an important event in vascular injury [3]. More
recent research has implicated the production of neutrophil extracellular traps (NETs) in ath-
erogenesis [4], although further research is required to fully define the underlying mechanisms
[5]. Other important hemostatic factors in atherosclerosis are monocytes/macrophages,
important inflammatory and invasive cells that regulate plaque formation and necrosis [2,6].
As they infiltrate the artery wall, monocytes polarize into different macrophage subsets that
play distinct roles in atherosclerosis [7].
MicroRNAs (miRNAs) are small, non-coding RNAs that posttranscriptionally regulate
gene expression by promoting mRNA degradation and/or inhibiting mRNA translation
[8,9]. Since their discovery, miRNAs have been implicated as key modulators of numerous
physiological and pathological processes. Their role in cardiovascular disease has been
extensively studied in recent years [10,11]. In particular, miR-146a has an anti-inflamma-
tory function [12] and its expression is regulated by the single-nucleotide polymorphism
(SNP) rs2431697; homozygote TT individuals have lower levels of miR-146a than GG
individuals [13]. We recently demonstrated that the levels of miR-146a in monocytes
may play an important role in the development of cardiovascular adverse events in
patients with atrial fibrillation (AF), with rs2431697-TT patients displaying higher risk of
developing adverse cardiovascular events [14]. In turn, monocytes from rs2431697-TT
individuals have an increased pro-inflammatory response when subjected to inflammatory
stress.
A role for miR-146a in atherosclerosis is suggested by its ability to negatively regulate
several pro-inflammatory factors that promote disease progression, including Toll-like
receptor 4 (TLR4), IL-1 receptor-associated kinase 1 (IRAK1), and TNF receptor-associated
protein factor 6 (TRAF6) [15,16]. Moreover, low miR-146a levels in neutrophils are associ-
ated with carotid intima-media thickening in patients with systemic lupus erythematosus
[17]. Recent mouse studies reveal that apolipoprotein E (ApoE) enhances miR-146a expres-
sion in monocytes and macrophages, suppressing NF-κB-mediated inflammation and
atherosclerosis, and that systemic delivery of miR-146a mimetic attenuates monocyte/macro-
phage activation and atherosclerosis in the absence of plasma lipid reduction [18]. Given
these recent studies and the relevance of leukocytes in all stages of atherosclerosis, we investi-
gated whether miR-146a deficiency restricted to the hematopoietic compartment can aggra-
vate the development of high-fat diet (HFD)-induced atherosclerosis in mice deficient for
the low-density lipoprotein receptor (Ldlr-/-) at early (8 weeks) and late stages (20 weeks) of
disease progression.
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Materials and methods
Mice and bone marrow transplantation
Animal welfare, and all experimental and other scientific procedures with animals conformed
to EU Directive 2010/63EU and Recommendation 2007/526/EC, enforced in Spanish law
under Real Decreto 53/2013. In addition, the animal research included in this work was
granted a formal ethics approval by the Committees in charge of animal welfare at Centro
Nacional de Investigaciones Cardiovasculares Carlos III (OEBA-CNIC) and Universidad de
Murcia (CEEA-UM), the Ethics Committee for Research from Universidad Autónoma de
Madrid (OH-UAM), the committee form the Animal Protection Area of the Comunidad
Autónoma de Madrid (CAM), and the Animal Health Service of the Department of Agricul-
ture and Water from Región de Murcia (DAW-RM). The ethics approval numbers from the
legally competent authorities are PROEX 134/14 (CAM) and A13150602 (DAW-RM). The
animals were housed in cages in ventilated racks. Cages contained a bed of wood chips and
nesting material, and objects for environmental enrichment. All the animals had ad libitum
access to food and water. The maximum number of animals per cage was limited to 5. Mice
were maintained under controlled environmental conditions (relative humidity: 45–65%; tem-
perature: 20–24 ˚C) with light/darkness cycles of 12h/12h.
miR-146a-/- mice (The Jackson laboratory, Bar Harbor, ME) were backcrossed for more
than 8 generations in a C57BL/6J CD45.2 background. Irradiation and bone marrow (BM)
transplantation was as described [19]. Briefly, Ldlr-/- CD45.1 mice (8 to 10-week-old, Charles
River) were irradiated with 2 doses of 6.5 Gy (10 minutes each, temperature: 37 ˚C) using a JL
Shephed & Associates 1-68A irradiator with a source of 1000 curies of Cs-137. Next day, the
animals were injected in the tail vein with 100μl of BM cells (7 x 106, in saline) obtained from a
pool of 4 femurs and 4 tibias of miR-146a-/- or wild-type (wt) mice (both C57BL/6J CD45.2;
8-week-old). After 4 weeks on a standard diet, transplanted mice were fed HFD for 8 or 20
weeks (10.7% total fat, 0.75% cholesterol, S9167-E010, SSNIFF, Germany). Transplant effi-
ciency was assessed as the percentage of donor CD45.2-immunoreactive cells in the blood of
BM recipient mice, assessed by CD45.2 and CD45.1 immunostaining and flow cytometry.
Animal were all euthanized at the end of every experiment by inhalation of carbon dioxide
gas.
Quantification of atherosclerosis burden and immunohistopathology
All quantitative analyses were performed by an investigator blinded to genotype. Atherosclero-
sis burden was quantified as described [20]. Briefly, mice were euthanized in a CO2 chamber
and the heart and aorta were extracted after in situ perfusion with PBS. Tissues were fixed with
4% paraformaldehyde/PBS overnight at 4˚C. Atherosclerosis burden was quantified by com-
puter-assisted morphometric analysis (SigmaScan pro 5, Systat Software Inc., San Jose, CA) of
the aortic arch stained with Oil Red O (O0625, Sigma, 0.2% Oil Red O in 80% MeOH) and of
hematoxylin/eosin-stained cross-sections from the aortic root; for each mouse, results were
the mean of 3 cross-sections. The area of the necrotic core in atheroma plaques was quantified
by analyzing hematoxylin/eosin-stained aortic cross-sections (mean of 3 cross-sections per
mouse).
Blood cell counting and biochemical parameters
Blood was extracted from the facial vein and was analyzed to quantify and identify circulating
blood cell populations using the PENTRA 80 hematology platform (HORIBA Medical,
Madrid, Spain). Plasma was isolated by centrifugation of whole blood (2000g, 15´ at room
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temperature), and lipid profile was obtained using DIMENSION RxL MAX (Siemens,
Munich, Germany).
Intravital microscopy
Male Ldlr-/- mice transplanted with BM wt or BM miR-146a-/- fed HFD for 20 weeks after
transplantation were used for cremaster muscle intravital microscopy as previously described
[21]. Briefly, once exteriorised, the cremaster muscle was placed onto an optical clear viewing
pedestal, cut longitudinally with a high temperature surgical cautery (Lifeline Medical) and
held extended at the corners of the exposed tissue using surgical suture. Ten min before image
acquisition, antibodies (0.5 μg) antiCD4 (Tonbo), anti-Ly6G (Biolegend) and anti-Ly6C
(eBioscience) were injected to label myeloid cell subsets. To maintain the correct temperature
and physiological conditions, exposed tissues were perfused continuously with 37˚C pre-
warmed Tyrode’s buffer solution (139 mM NaCl, 3 mM KCl, 17 mM NaHCO3, 12 mM Glu-
cose, 3 mM CaCl2 and 1 mM MgCl2). The cremasteric microcirculation was visualized using
an AXIO Examiner Z.1 work station (Zeiss) mounted on a 3-dimensional motorized stage
(Sutter Instrument) and equipped with a CoolSnap HQ2 camera (Photometrics). An APO
20x NA 1.0 water-immersion objective was used. Slidebook software 5.0 (Intelligent Imaging
Innovations) was employed for acquisition and image processing. Three randomly-selected
arterioles and venules were analysed per mouse, and T cells/monocytes/neutrophils were con-
sidered adherent when no rolling was observed using a reference line perpendicular to blood
flow for at least 30 seconds.
Quantitative real-time-PCR (qRT-PCR)
Total RNA was isolated from thoracic aortas using RNAzol reagent (Molecular Research Cen-
ter Inc) and was retrotranscribed (100 ng) using the SuperScript™ III First-Strand Synthesis
System (ThermoFisher). MiR-146a cDNA was synthesized using individual miRNA-specific
RT primers and the TaqMan1 MicroRNA Reverse Transcription Kit (ThermoFisher). cDNA
was amplified using TaqMan1 probes (Irak1: Mm01193538_m1, Traf6: Mm00493836_m1)
together with TaqMan1 Universal PCR Master Mix, No AmpErase1 UNG (ThermoFisher).
The 2-ΔCt method was used to calculate the relative abundance of mRNA compared with
endogenous actin (Actb: Mm02619580_g1) mRNA and of miRNA compared with U6 for
miR-146a (Ct = Threshold Cycle; ΔCt = Ct sample gene-Ct endogenous control).
Western blotting
Protein lysates were obtained from thoracic aortas of BM miR-146a-/-and BM wt transplanted
mice fed with a HFD for 20 weeks. Tissue homogenization was performed using TissueLyser
(Qiagen). Normalization was based on the amount of protein loaded. Total protein (20 μg)
was separated by SDS-PAGE (8%) in reducing conditions. Gels were transferred onto PVDF
membranes (Amersham Hybond P 0.45, GE Healthcare, Barcelona Spain) and blocked for 1
hour in 5% w/v BSA-TBS. Membranes were incubated overnight at 4˚C with primary antibod-
ies against human Traf6 (#sc-8409, 1:1,000, Santa Cruz, Heidelberg, Germany), Irak1 (D51G7,
1:1,000, Cell Signalling Technology, Leiden, The Netherlands), and β-actin (AC-15 clone,
1:5,000, Sigma-Aldrich, Madrid, Spain). After washing, membranes were incubated with sec-
ondary antibodies labeled with peroxidase (1:10,000, GE Healthcare, Barcelona, Spain). ECL
Prime Detection Kit and ImageQuant LAS 4000 Imager (GE Healthcare, Barcelona, Spain)
were used for protein detection. Densitometric analyses were performed with ImageJ software
(http://rsb.info.nih.gov/ij/).
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Statistical analysis
Data are presented as mean ±SEM. In experiments with 2 groups, statistical significance was
evaluated using a 2-tailed, unpaired Student’s t-test. For experiments comparing more than
one group, a 1 or 2-way ANOVA with the Bonferroni post hoc tests were performed (Graph-
Pad Prism software, La Jolla, CA). Differences were considered statistically significant at
P<0.05.
Results
Genetic disruption of miR-146a in hematopoietic cells does not increase
diet-induced atherosclerosis in Ldlr-/- mice
To assess whether miR-146a deficiency restricted to the hematopoietic compartment affects
atherosclerosis, Ldlr-/- mice (CD45.1 background) were transplanted with BM from miR-
146a-/- (BM miR-146a-/-) or wt (BM wt) mice (both CD45.2 background) (Fig 1A). After one
month, Ldlr-/- mice were examined to evaluate transplant efficiency by quantifying CD45.1
and CD45.2 expression in circulating blood cells. These studies revealed similar transplant effi-
ciency in both experimental groups (Fig 1B). Transplanted mice were then fed a HFD. Analysis
of BM miR-146a-/-and BM wt mice fed normal chow (pre-diet) and HFD (post-diet) revealed
no statistically significant between-group differences in body weight (Fig 1C). MiR-146a levels
in blood leukocytes were significantly decreased in BM miR-146a-/- transplanted mice before
and after HFD (Fig 1D). Moreover, in agreement with previously published results [22], we
found enlarged spleens and pale BM in miR-146a-/- transplanted mice (Fig 1E).
Circulating blood cell counts and populations were similar in both groups of mice, except
for platelets that were significantly reduced in BM miR-146a-/- after 20 weeks (Fig 2A). Plasma
levels of low-density lipoprotein cholesterol (LDL), total cholesterol, and triglycerides
increased significantly in both groups of mice fed HFD for 8 weeks compared with their pre-
diet values, but no statistically-significant between-group differences were observed (Fig 2B).
However, after 20 weeks of HFD, plasma lipid levels significantly decreased in BM miR-146a-/-
mice compared with BM wt mice (Fig 2B). Thus, genetic disruption of miR-146a in hemato-
poietic cells did not affect body weight, nor blood cell counts and populations, but reduced
plasma lipids after 20 weeks of HFD.
We next quantified atherosclerosis burden in fat-fed mice by planimetric analysis of whole-
mount Oil Red-O–stained aortic arch (Fig 3A) and hematoxylin/eosin-stained cross-sections
through the aortic root (Fig 3B) after 8 and 20 weeks of HFD. As expected, these studies
revealed increased atherosclerosis burden in mice of both groups at 20 weeks of HFD com-
pared with 8 weeks of HFD; however, atherosclerosis development at both times of HFD was
similar in BM miR-146a-/- and BM wt mice in all regions (Fig 3). Similarly, lack of miR-146a in
hematopoietic cells did not affect the formation of necrotic cores in the atherosclerotic plaques
of mice fed HFD for 8 and 20 weeks (Fig 3C).
Lack of miR-146a in hematopoietic cells does not augment adhesion of
leukocytes in fat fed Ldlr-/- mice
We next evaluated if miR-146a deficiency in the BM compartment may affect the recruitment
and adhesion of leukocytes to the inflamed vessel wall of Ldlr-/- mice fed HFD for 20 weeks.
For this purpose, we analyzed by intravital microscopy the in vivo adhesion of labeled leuko-
cytes (Ly6C+ monocytes, Ly6G+ neutrophils, and CD4+ T cells) to the endothelium of cremas-
ter muscle venules. These studies revealed no differences in the adhesion of the different
subtypes of leukocytes between BM miR-146a-/- and BM wt fat-fed Ldlr-/- mice (Fig 4).
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Expression of miR-146a targets in fat-fed mice
Thoracic aortas were homogenized and RNA extracted. As expected, the level of miR-146a
was lower in tissue from fat-fed BM miR-146a-/- mice compared with BM wt mice at both
times of HFD (Fig 5A). Accordingly, mRNA levels of the miR-146a targets Traf6 and Irak1
were significantly higher in thoracic aortas of BM miR-146a-/- mice after 8 weeks of HFD (Fig
5B). Similarly, Traf6 and Irak1 protein levels were significantly higher in thoracic aortas of BM
miR-146a-/- mice after 20 weeks of HFD (Fig 5C).
Discussion
There is increasing evidence connecting miRNAs with the molecular pathophysiological pro-
cesses leading to atherosclerosis (reviewed in [11,23]). Inflammation plays a pivotal role in all
Fig 1. Study design and efficiency of bone marrow transplantation. (A) Lethally-irradiated Ldlr-/- mice (CD45.1, 8 to 10-week-old) were transplanted with cells
obtained from bone marrow (BM) of wt or miR-146a-/- mice (both CD45.2). After 4 weeks of recovery, mice were challenged with a high-fat diet for 8 and 20
weeks. Blood and aorta were collected for biochemical and expression studies and to quantify atherosclerosis burden. (B) Quantification of transplant efficiency
in both groups of mice as determined by flow cytometry of blood extracted 1 month after BM transplant. Donor and host cells are CD45.2- and CD45.1-
immunoreactive, respectively. Representative flow cytometry profiles are shown below the chart. (C) Body weight at different times after the onset of HFD. (D) Pre
and post diet miR-146a levels in blood leukocytes were measured by qRT-PCR. The 2-ΔCt method was used to calculate miRNA abundance relative to U6
(Ct = Threshold Cycle; ΔCt = Ct sample gene − Ct endogenous control). : p<0.01, : p<0.001 BM wt vs BM miR-146a-/- at both time points. (E) Spleen from
BM wt or BM miR-146a-/- mice were weighed after 20 weeks of HFD. Shown are representative images of spleens and femurs.
https://doi.org/10.1371/journal.pone.0198932.g001
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stages of atherogenesis, from its initiation until plaque rupture [1,6]. MiR-146a was one of the
first miRNAs implicated in inflammatory processes [12]. Through the regulation of different
targets of the TLR/NF-κB pathway, miR-146a acts as a negative feedback regulator of the
innate immune response [24]. However, the implication of this miRNA in atherosclerosis has
been addressed only recently, and several questions remain. Defining the cells in which miR-
146a exerts its action will improve understanding of the role of this miRNA in atherogenesis.
Recently, Li et al. reported that the anti-atherogenic action of ApoE, which is highly expressed
in monocytes and macrophages, is mediated through increased expression of the transcription
factor PU.1, resulting in enhanced miR-146a expression in monocytes/macrophages and sup-
pression of NF-κB-driven inflammation [18]. These authors also found that systemic delivery
of miR-146a mimetic inhibits monocyte/macrophage activation and atherosclerosis develop-
ment [18]. We observed that lack of miR-146a in the hematopoietic compartment does not
affect atherosclerotic plaque formation in Ldlr-/- mice at early and late stages of disease pro-
gression (8 and 20 weeks of HFD). This finding was unexpected because inhibition of the
main miR-146a TLR/NF-κB pathway targets in monocytes/macrophages seemed to be protec-
tive [18]. Moreover, inhibition of NF-κB activation in macrophages increases atherosclerosis
in Ldlr-/- mice, although surprisingly the opposite occurs in endothelial cells [25]. This was fur-
ther demonstrated in a model of NEMO/IKKg deletion and upon endothelial cell-specific
expression of a dominant-negative IkBa mutant [26]. Different roles of a TLR/NF-κκB
Fig 2. Hematology and plasma lipids in transplanted Ldlr-/- mice. Lethally-irradiated Ldlr-/- mice (CD45.1, 8 to 10-week-old) were transplanted with cells
obtained from bone marrow (BM) of wt or miR-146a-/- mice (both CD45.2). After 4 weeks of recovery, mice were challenged with a high-fat diet (HFD) for 8 and
20 weeks. (A) Blood cell populations from BM wt or BM miR-146a-/- mice after HFD. (B) Plasma levels of LDL, total cholesterol, and triglycerides at 0, 8 and 20
weeks of HFD. : p<0.01, : p<0.001 BM wt vs BM miR-146a-/- at 20 weeks of HFD.
https://doi.org/10.1371/journal.pone.0198932.g002
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pathway component in endothelium vs. myeloid cells have also been described for TRAF6 by
Polykratis et al [27]. These authors showed that endothelial-cell-expressed TRAF6 induces the
expression of proinflammatory mediators that enhance the adhesion and recruitment of mac-
rophages to the endothelium, whereas in myeloid cells the opposite occurs, with TRAF6 defi-
ciency favoring the development of atherosclerosis by inhibiting the expression of IL-10 [27].
Our results demonstrate that decreasing the levels of miR-146a in the hematopoietic compart-
ment does not increase atherosclerosis at both early (8 weeks HFD) and late (20 weeks HFD)
stages of disease development. Of note, Cheng et al. recently showed no differences in athero-
sclerosis burden in the aortic arch of Ldlr-/- mice transplanted with BM miR-146a-/-and fed
HFD for 4 weeks; however, they found a significant decrease in plaque burden in BM miR-
146a-/- Ldlr-/- mice after 12 weeks of HFD [22]. Importantly, these authors observed unchanged
Fig 3. Ablation of miR-146a gene in hematopoietic cells does not affect diet-induced atherosclerosis in Ldlr-/- mice. Lethally-irradiated Ldlr-/- mice (CD45.1, 8
to 10-week-old) were transplanted with cells obtained from bone marrow (BM) of wt or miR-146a-/- mice (both CD45.2). After 4 weeks of recovery, mice were
challenged with a high-fat diet (HFD). Mice were euthanized after 8 or 20 weeks of HFD and tissues were harvested for immunohistopathological characterization
of atherosclerotic lesions. Representative images are shown in each panel. (A) Percentage of aortic arch are occupied by atheroma visualized by en face Oil Red O
staining. (B) Quantification of atheroma size in hematoxylin/eosin-stained sections of the aortic sinus. (C) Area of atherosclerotic lesions occupied by necrotic
cores quantified in histological sections from the aortic sinus. : p<0.05, : p<0.001 vs same BM genotype at 20 weeks of HFD.
https://doi.org/10.1371/journal.pone.0198932.g003
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plaque burden in the descending thoracic aorta and aortic root at both time points with HFD.
Among other reasons, Cheng et al. suggested that low levels of cholesterol after 12 weeks of
HFD might explain this atheroprotective role in aortic arch provoked by a miR-146a defi-
ciency in the hematopoietic compartment [22]. We also observed a significant decline in cho-
lesterol after 20 weeks of HFD in BM miR-146a-/-, but this was not sufficient to reduce plaque
burden under our experimental conditions. Consistent with our results showing no differences
in atherosclerosis development in fat-fed BM miR-146a-/- Ldlr-/- mice, our intravital micros-
copy studies revealed no differences in vascular leukocyte recruitment upon miR-146a-/- defi-
ciency in BM cells.
Paradoxically it has also been described that inhibiting miR-146a in endothelial cells may
increase the expression of some of its targets, such as TRAF6, thus enhancing NF-κB activation
and promoting atherogenesis [28]. Indeed, Cheng et al. also demonstrated that mice deficient
for miR-146a except in the hematopoietic compartment have a significant increase in athero-
sclerotic plaque burden in comparison with mice lacking miR-146a in all cells [22]. In line
with these results, endothelium-specific delivery of miR-146a-loaded E-selectin-targeting
microparticles reduced atherosclerosis in ApoE-/-mice [29]. In their study of the effect of sys-
temically delivered miR-146a mimetics, Li et al. examined expression of endogenous miR-
Fig 4. Deletion of miR-146a gene in hematopoietic cells does not increase adhesion in Ldlr-/- mice fed HFD. Lethally-irradiated Ldlr-/- mice (CD45.1, 8 to
10-week-old) were transplanted with cells obtained from bone marrow (BM) of wt or miR-146a-/- mice (both CD45.2). After 4 weeks of recovery, mice were
challenged with a high-fat diet (HFD) for 20 weeks and analyzed by intravital microscopy in the cremaster muscle. Images are representative for Ly6C+ monocytes,
Ly6G+ neutrophils, and CD4+ T cells adhered to the wall of cremasteric venules. Dashed lines mark the boundaries of the venules.
https://doi.org/10.1371/journal.pone.0198932.g004
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146a in leukocytes, but not in the aorta [18]. It is therefore possible that this treatment
increased miR-146a levels predominantly in endothelium, as reported for in vivo injection of
miRNA mimetics in other studies [30,31]. Thus, the potential beneficial effect of miR-146a in
atherosclerosis might be due in part to increased expression in endothelial cells. Thus, despite
observing no differences in atherosclerosis burden, we found above-normal expression of
specific targets of miR-146a such as Traf6 and Irak1 in the aorta of BM 146a-/- mice, which
exhibited low level of miR-146a expression. Since levels of miR-146a expression in non-
hematopoietic cells are unaffected by BM transplantation, differences in the expression of
miR-146a and its two targets Traf6 and Irak1 might be due to variations in infiltrated leuko-
cytes. Since miR-146a deficiency does not increase leukocyte adhesion, leukocyte infiltration
should be similar in BM miR-146a-/- and BM wt mice. Thus, miR-146a deficiency in hemato-
poietic cells affects miR146a targets in the inflamed aorta but not sufficiently to aggravate ath-
erosclerosis development in Ldlr-/- mice. Future studies using conditional miR146a-deficient
mice for endothelium or vascular smooth muscle cells may help to unequivocally establish this
Fig 5. Expression of miR-146a targets in fat-fed mice. Lethally-irradiated Ldlr-/- mice (CD45.1, 8 to 10-week-old) were transplanted with cells obtained from
bone marrow (BM) of wt or miR-146a-/- mice (both CD45.2). After 4 weeks of recovery, mice were challenged with a high-fat diet (HFD) for the indicated
times. (A) miR-146a expression was measured by qRT-PCR in total RNA extracted from the thoracic aorta of mice fed high-fat diet (HFD) for 8 weeks
(individual thoracic aortas) and 20 weeks (pools of 3 thoracic aortas per samples). (B) miR-146a targets Irak1 and Traf6 mRNA levels were measured by
qRT-PCR after 8 weeks of HFD. The 2-ΔCt method was used to calculate miRNA/mRNA abundance relative to endogenous control expression (U6 in A; β-actin
in B) (Ct = Threshold Cycle; ΔCt = Ct sample gene − Ct endogenous control). (C) Representative western blot and quantification of Irak1 and Traf6 protein
levels (normalized to β-actin) in thoracic aorta of mice receiving BM wt or BM miR-146a-/- after 20 weeks of HFD (pools of 3 thoracic aortas per sample). :
p<0.05, : p<0.01 BM wt vs BM miR-146a-/- at both time points.
https://doi.org/10.1371/journal.pone.0198932.g005
miR-146a and atherosclerosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0198932 June 14, 2018 10 / 13
hypothesis. Additionally, since miR-146a-/- mice still express miR-146b, which shares most of
the targets with miR-146a, we cannot discard that miR-146b has a compensatory effect in the
setting of atherosclerosis model [32]. In conclusion, our results strongly suggest that miR-146a
expressed in the hematopoietic compartment plays a negligible role in atherosclerosis develop-
ment in Ldlr-/- mice, although its ablation increases in the aorta the proinflammatory state pro-
moted by an atherogenic diet. Identifying how expression of this miRNA limits atherosclerosis
remains of high interest. It will therefore be important to develop in vivo models in which to
investigate the cells, with special attention to endothelial cells, in which miR-146a exerts its
anti-atherogenic function. Finally, investigating the effect of low levels of miR-146a in humans
due for example to rs2431697 in atherosclerosis may be of interest to evaluate the clinical
impact of a partial miR-146a deficiency.
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Conceptualization: Rocı́o González-Conejero, Constantino Martı́nez, Vicente Andrés.
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